cancer treatment and research

[1] Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

[2] A conditional inducible JAK2V617F transgenic mouse model reveals myeloproliferative disease that is reversible upon switching off transgene expression.

[3] jak2v617f: is it sufficient as a single player in splanchnic venous thrombosis?

[4] the european clinical, molecular, and pathological (ecmp) criteria and the 2007/2008 revisions of the world health organization for the diagnosis, classification, and staging of prefibrotic myeloproliferative neoplasms carrying the jak2v617f mutation